Literature DB >> 32217025

Early prediction of moderate to severe bronchopulmonary dysplasia in extremely premature infants.

Amit Sharma1, Yuemin Xin2, Xinguang Chen3, Beena G Sood4.   

Abstract

BACKGROUND: Bronchopulmonary Dysplasia (BPD) is the commonest morbidity in extremely preterm infants (PTIs). Risk factors for BPD have been described in the era before the widespread availability of non-invasive ventilation (NIV) in the delivery room (DR). The objective of this study is to identify risk factors for Moderate/Severe BPD in an era of widespread availability of NIV in the DR.
METHODS: Detailed antenatal and postnatal data were abstracted for PTIs, 230/7-276/7 weeks GA. Multivariate logistic regression and classification and regression tree analyses (CART) identified predictors for the primary outcome of Moderate/Severe BPD.
RESULTS: Of 263 eligible infants, 59% had Moderate/Severe BPD. Moderate/Severe BPD was significantly associated with birthweight, gender, DR intubation and surfactant compared to No/Mild BPD. Of infants not intubated in the DR, 40% with No/Mild BPD and 80% with Moderate/Severe BPD received intubation by 48 hours (p < 0.05). Infants with Moderate/Severe BPD received longer duration of oxygen and mechanical (MV). On logistic regression, birthweight, gender, oxygen concentration, cumulative duration of oxygen and MV, surfactant, and blood transfusions predicted Moderate/Severe BPD. Both CART analysis and logistic regression showed duration of oxygen and MV to be the most important predictors for Moderate/Severe BPD.
CONCLUSIONS: In an era of increasing availability of NIV in the DR, lower birthweight, male gender, surfactant treatment, blood transfusions and respiratory support in the first 2-3 weeks after birth predict Moderate/Severe BPD with high sensitivity and specificity. The majority of these infants received intubation within 48 hours of birth (97%). These data suggest that early failures of NIV represent opportunities for improvement of NIV techniques and of non-invasive surfactant to avoid intubation in the first 48 hours. Furthermore, these risk factors may allow earlier identification of infants most likely to benefit from interventions to prevent or decrease severity of BPD.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  bronchopulmonary dysplasia; extremely premature infants; prediction

Year:  2019        PMID: 32217025     DOI: 10.1016/j.pedneo.2019.12.001

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  7 in total

1.  Increased Risk for Respiratory Complications in Male Extremely Preterm Infants: A Propensity Score Matching Study.

Authors:  Zhiwen Su; Lili Lin; Xi Fan; Chunhong Jia; Bijun Shi; Xiaoxia Huang; Jianwei Wei; Qiliang Cui; Fan Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-12       Impact factor: 6.055

2.  Lung ultrasound predicts the development of bronchopulmonary dysplasia: a prospective observational diagnostic accuracy study.

Authors:  Xiaolei Liu; Xiaoming Lv; Di Jin; Heng Li; Hui Wu
Journal:  Eur J Pediatr       Date:  2021-03-23       Impact factor: 3.183

3.  Vitamin A supplementation prevents the bronchopulmonary dysplasia in premature infants: A systematic review and meta-analysis.

Authors:  Yueqin Ding; Zhifeng Chen; Yanling Lu
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

4.  Successful treatment of infantile oxysterol 7α-hydroxylase deficiency with oral chenodeoxycholic acid.

Authors:  Yun-Ping Tang; Jing-Yu Gong; Kenneth D R Setchell; Wujuan Zhang; Jing Zhao; Jian-She Wang
Journal:  BMC Gastroenterol       Date:  2021-04-13       Impact factor: 3.067

5.  Development and verification of a risk prediction model for bronchopulmonary dysplasia in very low birth weight infants.

Authors:  Huiwen Cai; Ling Jiang; Yongshu Liu; Ting Shen; Zuming Yang; Sannan Wang; Yuelan Ma
Journal:  Transl Pediatr       Date:  2021-10

6.  Positive versus negative pressure during removal of endotracheal-tube on prevention of post-extubation atelectasis in ventilated neonates: A randomized controlled trial.

Authors:  Roya Farhadi; Maryam Nakhshab; Atefeh Hojjati; Mohammad Khademloo
Journal:  Ann Med Surg (Lond)       Date:  2022-04-04

Review 7.  Serum and Urinary N-Terminal Pro-brain Natriuretic Peptides as Biomarkers for Bronchopulmonary Dysplasia of Preterm Neonates.

Authors:  Zoi Iliodromiti; Evangelos Christou; Nikolaos Vrachnis; Rozeta Sokou; Dionysios Vrachnis; Georgia Mihopoulou; Theodora Boutsikou; Nicoletta Iacovidou
Journal:  Front Pediatr       Date:  2020-10-28       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.